Rhabdomyosarcoma development in mice lacking Trp53 and Fos - Tumor suppression by the Fos protooncogene

Author： Fleischmann A.   Jochum W.   Eferl R.   Witowsky J.   Wagner E.F.  

Publisher： Elsevier

ISSN： 1535-6108

Source： Cancer Cell, Vol.4, Iss.6, 2003-12, pp. : 477-482

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Mice Lacking MSK1 and MSK2 Show Reduced Skin Tumor Development in a Two-Stage Chemical Carcinogenesis Model

By Chang Simon   Iversen Lars   Kragballe Knud   Arthur J. Simon C.   Johansen Claus  

Cancer Investigation, Vol. 29, Iss. 3, 2011-02 ,pp. : 240-245

Informa Healthcare

Access to resources Recommend Favorite

RGS16 and FosB underexpressed in pancreatic cancer with lymph node metastasis promote tumor progression

By Kim Ji  

Tumor Biology, Vol. 31, Iss. 5, 2010-10 ,pp. : 541-548

Springer Publishing Company

Access to resources Recommend Favorite

Human osteosarcoma cells respond to sorafenib chemotherapy by downregulation of the tumor progression factors S100A4, CXCR4 and the oncogene FOS

By              

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1147-1156

Spandidos Publications

Access to resources Recommend Favorite

Loss of Expression of the p16 Tumor Suppressor Gene Is More Frequent in Advanced Ovarian Cancers Lacking p53 Mutations

By Havrilesky L.J.   Alvarez A.A.   Whitaker R.S.   Marks J.R.   Berchuck A.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 491-500

Elsevier

Access to resources Recommend Favorite

Estradiol suppresses neuronal firing activity and c-Fos expression in the lateral habenula

By            

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 4410-4414

Spandidos Publications

Access to resources Recommend Favorite